Literature DB >> 15861265

Nongastrointestinal symptoms of irritable bowel syndrome: an office-based clinical survey.

N B Hershfield1.   

Abstract

Irritable bowel syndrome (IBS) is the most prevalent gastrointestinal problem faced by practicing gastroenterologists. For many years, nongastrointestinal symptoms have been documented in IBS patients, but the medical literature does not emphasize them. The present study explored how IBS and inflammatory bowel disease patients differ in their reporting of nongastrointestinal symptoms. Information from 200 consecutive patients with IBS and a similar number of patients with Crohn's disease (in a single gastroenterology practice) was obtained at the initial visit using a simple questionnaire. Comparison of the data revealed that IBS patients describe certain nongastrointestinal symptoms far more frequently than do those with inflammatory bowel disease. It is recommended that these symptoms be considered along with the generally accepted criteria for making a positive diagnosis of IBS.

Entities:  

Mesh:

Year:  2005        PMID: 15861265     DOI: 10.1155/2005/978794

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  4 in total

Review 1.  Irritable bowel syndrome: a clinical review.

Authors:  Rosa L S Soares
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

2.  A case of parasite invasion of the intestinal tract: a missed diagnosis in irritable bowel syndrome.

Authors:  Kang Hun Koh; Sang Wook Kim; So Young Lee; Hee Jung Lee; Hea Min Yu; Byung Jun Jeon; Dae Hun Kwon; Soo Teik Lee
Journal:  Clin Endosc       Date:  2013-11-19

Review 3.  Gastrointestinal Headache; a Narrative Review.

Authors:  Majid T Noghani; Hossein Rezaeizadeh; Sayed Mohammad Baqer Fazljoo; Mansoor Keshavarz
Journal:  Emerg (Tehran)       Date:  2016-11

4.  Irritable bowel syndrome and migraine: bystanders or partners?

Authors:  Full-Young Chang; Ching-Liang Lu
Journal:  J Neurogastroenterol Motil       Date:  2013-07-08       Impact factor: 4.924

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.